Oznacznie antygrzybiczej aktywnosci biobojczego preparatu Enizol

• Autorzy: Ziolkowska G , Tokarzewski S.

Warianty tytułu

EN

Determination of antifungal activity of Enizol: a specific disinfecting preparation

• Języki publikacji: PL

Abstrakty

EN

The objective of the present study was to evaluate the antifungal activity of Enizol, a new disinfecting preparation with enilkonazole as the active substance. For both the studies in vitro and in vivo the initial concentration of Enizol was constituted by an aqueous solution of the preparation at a ratio of 1:100. The investigations covered 34 strains of the following mould fungi: A. fumigatus (n=5), A. versicolor (n=3), Penicillium spp. (n=5), Cladosporium spp. (n=4), Scopulariopsis spp. (n=3), Fusarium spp. (n=4), Alternaria spp. (n=5), Mucor spp. (n=5), as well as 10 strains of yeast-like fungi: Candida albicans (n=5) and Candida non-albicans (n=5). The minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC) of Enizol were determined in vitro according to NCCLS M27-A and by a cylinder dilution method. The MIC values for these organisms appeared to be differentiated and ranged from 0.07 µgml-1 (A. versicolor) up to 37.5 µgml⁻¹ (Mucor spp.). A group of extremely sensitive fungi comprised Aspergillus spp. (0.07 - 1.2 µgml⁻¹), Penicillium spp. (0.07 - 1.2 µgml⁻¹) and Alternaria spp. (2.4 µgml⁻¹); Cladosporium spp. genus (4.75 µgml-1) indicated the medium susceptibility toward the inhibitory activity of Enizol, whereas Fusarium spp. (9.5 µgml⁻¹), Mucor spp. (19.0 - 37.5 µgml⁻¹) and Scopulariopsis spp. (19.0 µgml⁻¹) had the lowest values. The antifungal efficacy of the studied preparation is confirmed by its lethal characteristics. The minimal fungicidal concentrations (MFC) were differentiated subject to the species of fungus studied. At the same time the sensitivity of the anascogenic yeast Candida genus was analyzed and consequently the fungi were classified among the organisms relatively resistant to (9.5 µgml⁻¹ MIC, 37.5 µgml⁻¹ MFC) Enizol activity. The studies in vivo confirmed the sensitivity of fimbriate fungi to the preparation and, usually, this was consistent with the tests in vitro. At the same time the antifungal efficacy of Enizol in vivo was demonstrated towards the fungi Candida genus, which indicates its usability as a lethal preparation in an environment where animals stay.

Słowa kluczowe

PL

minimalne stezenia grzybobojcze; zwalczanie; minimalne stezenia hamujace; aktywnosc przeciwgrzybicza; grzyby drozdzoidalne; infekcja grzybowa; preparaty przeciwgrzybicze; drob; preparat Enizol; gesi

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2006
• Tom: 62
• Numer: 07
• Opis fizyczny: s.792-796,tab.,bibliogr.

Twórcy

autor

Ziolkowska G

• Akademia Rolnicza, ul.Akademicka 12, 20-033 Lublin

autor

Tokarzewski S.

Bibliografia

• 1. Akan M., Haziroğlu M., Ĵlham Z., Sareyyűpoğlu B., Tunca R.: A case of aspergillosis in a broiler breeder flock. Avian Dis. 2002, 46, 497-501.
• 2. Anon.: Clinafarm® Fungicide Technical Manual. Millsboro D. E.: Mallincrodt Vet. Inc. 1995.
• 3. Atasever A., Gümüşsoy K. S.: Pathological, clinical and mycological findings in experimental aspergillosis infections of starlings. J. Vet. Med. A 2004, 51, 19-22.
• 4. Diekema D. J., Messer S. A., Hollis R. J., Jones R. N., Pfaller M. A.: Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole and amphotericin B against 448 recent clinical isolates of filamentous fungi. J. Clin. Microbiol. 2003, 41, 3623-3626.
• 5. Flemming R., Walsh T. J., Anaissie E.: Emerging and less common fungal pathogens. Infecy. Dis. Clin. N. Am. 2002, 16, 915-933.
• 6. Gümüşsoy K. S., Uyanik F., Atasever A., Çam Y.: Experimental Aspergillus fumigatus infection in quails and results of treatment with itraconazole. J. Vet. Med. B 2004, 51, 34-38.
• 7. Hnilica K. A., Medleau L.: Evaluation of topically applied enilconazole for the treatment of dermatophytosis in a Persian cattery. Vet. Dermatol. 2002, 13, 23-28.
• 8. Lin M. Y., Huang K. J., Kleven S. H.: In vitro comparison of the activity of various antifungal drugs against new yeast isolates causing thrush in poultry. Avian Dis. 1989, 33, 416-421.
• 9. Maertens J., Verbos M., Boogaerts M.: Assessing risk factors for systemic fungal infections. Eur. J. Cancer Care 2001, 10, 56-62.
• 10. Meletiadis J., te Dorsthorst D. T. A., Verweij P. E.: Use of turbidimetric growth curves for early determination of antifungal drug resistance of filamentous fungi. J. Clin. Microbiol. 2003, 41, 4718-4725.
• 11. Mueller M., de la Peña A., Derendorf H.: Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC. Antimicrob. Agents Chemother. 2004, 48, 369-377.
• 12. Odds F. C., Brown A. J. P., Gow N. A. R.: Antifungal agents: mechanisms of action. Trends Microbiol. 2003, 11, 272-279.
• 13. Orosz S., Frazier D. L.: Antifungal agents: a review of their pharmacology and therapeutic indications. J. Avian Med. Surgery 1995, 9, 8-18.
• 14. Pfaller M. A., Diekema D. J.: Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J. Clin. Microbiol. 2004, 42, 4419-4431.
• 15. Pfaller M. A., Diekema D. J.: Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin. Microbiol. Infect. (Suppl. 1) 2004, 10, 11-23.
• 16. Pfaller M. A., Sheehan D. J., Rex J. H.: Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization. Clin. Microbiol. Rev. 2004, 17, 268-280.
• 17. Reding P. T., Duke G. E.: Comparative pharmacokinetics of antifungal drug in domestic turkeys, red-tailed hawks, broad-winged hawks and great-horned owls. Avian Dis. 1985, 29, 649-661.
• 18. Redmann T., Schildger B.: Therapeutic use of enilconazole in broiler chicks with aspergillosis. Dt. Tierärztl. Wschr. 1989, 96, 15-17.
• 19. Reece R. L., Taylor T. K., Dickson D. B.: Mycosis of commercial Japanese quail, ducks and turkeys. Aust. Vet. J. 1986, 63, 196-197.
• 20. Rex J. H., Pfaller M. A., Walsh T. J., Chaturvedi V., Espinel-Ingroff A., Ghannoum M. A., Gosey L. L., Odds F. C., Rinaldi M. G., Sheehan D. J., Warnock D. W.: Antifungal susceptibility testing: practical aspects and current challenges. Clin. Microbiol. Rev. 2001, 14, 643-658.
• 21. Rochette F., Engelen M., Vanden Bossche H.: Antifungal agents of use in animal health - practical applications. J. Vet. Pharmacol. Ther. 2003, 26, 31-53.
• 22. Rochette F.: The battle against aspergillosis. Poultry-Misset. 1985, 4, 54-57.
• 23. St-Germain G., Summerbell R.: Identifying Filamentus Fungi. A Clinical Laboratory Handbook. Star Publishing Company, Belmont, California 1996.
• 24. Uchida K., Kokota N., Yamaguchi H.: In vitro antifungal activity of posaconazole against various pathogenic fungi. Int. J. Antimicrob. Agents 2001, 18, 167-172.
• 25. Van Cutsem J., Van Gerven F., Janssen P. A. J.: Le traitement de l'aspergillose experimentale par l'enilkonazole et par itraconazole. Bull. Soc. Française de Mycologie Medicale 1989, 18, 55-59.
• 26. Vanden Bossche H., Engelen M., Rochette F.: Antifungal agents of use in animal health-chemical, biochemical and pharmacological aspects. J. Vet. Pharmacol. Ther. 2003, 26, 5-29.
• 27. Walsh T. J., Groll A., Jimenez J., Flemming R., Roilides E., Anaissie E.: Infections due to emerging and uncommon medically important fungal pathogens. Clin. Microbiol. Infect. 2004, 10, 48-66.
• 28. Wawrzkiewicz K., Ziółkowska G., Sadzikowski Z.: Oznaczanie wrażliwości dermatofitów na preparaty przeciwgrzybowe cylinderkową metodą rozcieńczeń w agarze. Medycyna Wet. 2000, 56, 648-652.
• 29. White-Wheiters N., Medleau L.: Evaluation of topical therapies for the treatment of dermatophyte-infected hairs from dogs and cats. J. Am. Anim. Hosp. Ass. 1995, 31, 250-253.
• 30. Wyatt R. D., Hamilton P. B.: Candida species and crop mycosis in broiler chickens. Poultry Sci. 1975, 54, 1663-1666.
• 31. Ziółkowska G., Tokarzewski S.: Występowanie grzybów drożdżopodobnych w stadach gęsi reprodukcyjnych. Medycyna Wet. 2005, 61, 1181-1185.